The Science Behind EXOSOMM: Unleashing Nature's Delivery System
Transforming milk exosomes into scalable wellness solutions backed by over a decade of patented research and clinical validation.
Milk Exosomes: Nature’s Therapeutic Nanocarriers
Milk exosomes are nano-sized vesicles (30-150nm) naturally present in mammalian milk that serve as sophisticated cellular communication tools. These biological nanoparticles contain:
• Specific proteins that facilitate targeted delivery
• miRNAs that regulate gene expression
• Lipid bilayer membranes that provide exceptional stability
• Natural biocompatibility with human systems
​
Unlike synthetic delivery systems, milk exosomes evolved specifically to transport bioactive compounds between organisms, making them uniquely effective for therapeutic applications.
A Decade of Scientific Validation
EXOSOMM’s patented research, conducted at the world-renowned Hadassah Medical Center, provides a robust foundation for our claims. Our studies consistently demonstrate that milk exosomes significantly reduce inflammation in both preclinical and clinical settings.
The successful completion of our first-in-human trial further validates their exceptional safety and efficacy, positioning milk exosomes as a groundbreaking, natural alternative to conventional anti-inflammatory drugs.
Breakthrough Technology
We’ve developed a proprietary, chemical-free process to isolate milk exosomes from dairy side-streams (whey), preserving their bioactivity and enabling industrial-scale production. Our powdered ingredients retain crucial miRNA cargo often lost in conventional processing, offering long shelf life and broad application potential.
From Lab to Market
With GRAS regulatory clearance and a production capacity of 200 MT annually, EXOSOMM is the first company to bring bioactive milk exosomes to market at scale.
Our platform supports a wide range of applications:
-
Medical Foods
-
Nutraceuticals
-
Skin Care
-
Functional Nutrition
